This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niesters, H. G. M.
Right arrow Articles by Osterhaus, A. D. M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niesters, H. G. M.
Right arrow Articles by Osterhaus, A. D. M. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2000, p. 712-715, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Development of a Real-Time Quantitative Assay for Detection of Epstein-Barr Virus

Hubert G. M. Niesters,1,* Joost van Esser,2 Edwin Fries,1 Katja C. Wolthers,1 Jan Cornelissen,2 and Albert D. M. E. Osterhaus1

Departments of Virology1 and Haematology,2 University Hospital Rotterdam, Rotterdam, The Netherlands

Received 21 July 1999/Returned for modification 20 September 1999/Accepted 23 November 1999

With the use of real-time PCR, we developed and evaluated a rapid, sensitive, specific, and reproducible method for the detection of Epstein-Barr virus (EBV) DNA in plasma samples. This method allowed us to screen plasma and serum samples over a range between 100 and 107 copies of DNA per ml using two sample preparation methods based on absorption. A precision study yielded an average coefficient of variation for both methods of less than 12%, with a coefficient of regression for the standard curve of a minimum of 0.98. We detected EBV DNA in 19.2% of plasma samples from immunosuppressed solid-organ transplant patients without symptoms of EBV infections with a mean load of 440 copies per ml. EBV DNA could be detected in all transplant patients diagnosed with posttransplant lymphoproliferative disorder, with a mean load of 544,570 copies per ml. No EBV DNA could be detected in healthy individuals in nonimmunosuppressed control groups and a mean of 6,400 copies per ml could be detected in patients with infectious mononucleosis. Further studies revealed that the inhibitory effect of heparinized plasma could be efficiently removed by use of an extraction method with Celite as the absorbent.

* Corresponding author. Mailing address: Department of Virology, University Hospital Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: 31-10-463.3431. Fax: 31-10-463.3441. E-mail: niesters{at}viro.fgg.eur.nl.

Journal of Clinical Microbiology, February 2000, p. 712-715, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Wolffs, P. F. G., Vink, C., Keijdener, J., Habek, B., Reijans, M., Simons, G., Bruggeman, C. A., van den Brule, A. J. C. (2009). Evaluation of MeningoFinder, a Novel Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Six Virus Species Causing Central Nervous System Infections. J. Clin. Microbiol. 47: 2620-2622 [Abstract] [Full Text]  
  • Gunson, R. N., Maclean, A. R., Shepherd, S. J., Carman, W. F. (2009). Simultaneous Detection and Quantitation of Cytomegalovirus, Epstein-Barr Virus, and Adenovirus by Use of Real-Time PCR and Pooled Standards. J. Clin. Microbiol. 47: 765-770 [Abstract] [Full Text]  
  • Gulley, M. L., Tang, W. (2008). Laboratory Assays for Epstein-Barr Virus-Related Disease. J. Mol. Diagn. 10: 279-292 [Abstract] [Full Text]  
  • McManus, T. E., Marley, A-M., Baxter, N., Christie, S. N., Elborn, J. S., O'Neill, H. J., Coyle, P. V., Kidney, J. C. (2008). High levels of Epstein-Barr virus in COPD. Eur Respir J 31: 1221-1226 [Abstract] [Full Text]  
  • Fafi-Kremer, S., Morand, P., Barranger, C., Bargues, G., Magro, S., Bes, J., Bourgeois, P., Joannes, M., Seigneurin, J.-M. (2008). Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms. J. Mol. Diagn. 10: 78-84 [Abstract] [Full Text]  
  • Jakubowski, A. A., Small, T. N., Young, J. W., Kernan, N. A., Castro-Malaspina, H., Hsu, K. C., Perales, M.-A., Collins, N., Cisek, C., Chiu, M., van den Brink, M. R. M., O'Reilly, R. J., Papadopoulos, E. B. (2007). T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 110: 4552-4559 [Abstract] [Full Text]  
  • Hakim, H., Gibson, C., Pan, J., Srivastava, K., Gu, Z., Bankowski, M. J., Hayden, R. T. (2007). Comparison of Various Blood Compartments and Reporting Units for the Detection and Quantification of Epstein-Barr Virus in Peripheral Blood. J. Clin. Microbiol. 45: 2151-2155 [Abstract] [Full Text]  
  • Miura-Ochiai, R., Shimada, Y., Konno, T., Yamazaki, S., Aoki, K., Ohno, S., Suzuki, E., Ishiko, H. (2007). Quantitative Detection and Rapid Identification of Human Adenoviruses. J. Clin. Microbiol. 45: 958-967 [Abstract] [Full Text]  
  • Kalpoe, J S, Douwes Dekker, P B, van Krieken, J H J M, Baatenburg de Jong, R J, Kroes, A C M (2006). Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area. J. Clin. Pathol. 59: 537-541 [Abstract] [Full Text]  
  • Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R. III, Smith, T. F. (2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin. Microbiol. Rev. 19: 165-256 [Abstract] [Full Text]  
  • Piriou, E., van Dort, K., Nanlohy, N. M., van Oers, M. H. J., Miedema, F., van Baarle, D. (2005). Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood 106: 3166-3174 [Abstract] [Full Text]  
  • Thijsen, S. F. T., Luderer, R., van Gorp, J. M. H., Oudejans, S. J. G., Bossink, A. W. J. (2005). A possible role for Epstein-Barr virus in the pathogenesis of pleural effusion. Eur Respir J 26: 662-666 [Abstract] [Full Text]  
  • Buljevac, D, van Doornum, G J J, Flach, H Z, Groen, J, Osterhaus, A D M E, Hop, W, van Doorn, P A, van der Meche, F G A, Hintzen, R Q (2005). Epstein-Barr virus and disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 76: 1377-1381 [Abstract] [Full Text]  
  • Piriou, E., Jansen, C. A., Dort, K. v., De Cuyper, I., Nanlohy, N. M., Lange, J. M. A., van Oers, M. H. J., Miedema, F., van Baarle, D. (2005). Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy. J. Immunol. 175: 2010-2017 [Abstract] [Full Text]  
  • Claas, E. C. J., Schilham, M. W., de Brouwer, C. S., Hubacek, P., Echavarria, M., Lankester, A. C., van Tol, M. J. D., Kroes, A. C. M. (2005). Internally Controlled Real-Time PCR Monitoring of Adenovirus DNA Load in Serum or Plasma of Transplant Recipients. J. Clin. Microbiol. 43: 1738-1744 [Abstract] [Full Text]  
  • Milone, M. C., Tsai, D. E., Hodinka, R. L., Silverman, L. B., Malbran, A., Wasik, M. A., Nichols, K. E. (2005). Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 105: 994-996 [Abstract] [Full Text]  
  • Feng, W.-h., Cohen, J. I., Fischer, S., Li, L., Sneller, M., Goldbach-Mansky, R., Raab-Traub, N., Delecluse, H.-J., Kenney, S. C. (2004). Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas. JNCI J Natl Cancer Inst 96: 1691-1702 [Abstract] [Full Text]  
  • Piriou, E. R., van Dort, K., Nanlohy, N. M., Miedema, F., van Oers, M. H., van Baarle, D. (2004). Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma. J. Immunol. 172: 6931-6937 [Abstract] [Full Text]  
  • Malbran, A., Belmonte, L., Ruibal-Ares, B., Bare, P., Massud, I., Parodi, C., Felippo, M., Hodinka, R., Haines, K., Nichols, K. E., de Bracco, M. M. (2004). Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 103: 1625-1631 [Abstract] [Full Text]  
  • Kang, I., Quan, T., Nolasco, H., Park, S.-H., Hong, M. S., Crouch, J., Pamer, E. G., Howe, J. G., Craft, J. (2004). Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus. J. Immunol. 172: 1287-1294 [Abstract] [Full Text]  
  • Polstra, A. M., van den Burg, R., Goudsmit, J., Cornelissen, M. (2003). Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma. J. Clin. Microbiol. 41: 5488-5491 [Abstract] [Full Text]  
  • Wadowsky, R. M., Laus, S., Green, M., Webber, S. A., Rowe, D. (2003). Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR. J. Clin. Microbiol. 41: 5245-5249 [Abstract] [Full Text]  
  • Meij, P., van Esser, J. W. J., Niesters, H. G. M., van Baarle, D., Miedema, F., Blake, N., Rickinson, A. B., Leiner, I., Pamer, E., Lowenberg, B., Cornelissen, J. J., Gratama, J. W. (2003). Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 101: 4290-4297 [Abstract] [Full Text]  
  • Jaye, D. L., Nolte, F. S., Mazzucchelli, L., Geigerman, C., Akyildiz, A., Parkos, C. A. (2003). Use of Real-Time Polymerase Chain Reaction to Identify Cell- and Tissue-Type-Selective Peptides by Phage Display. Am. J. Pathol. 162: 1419-1429 [Abstract] [Full Text]  
  • Jebbink, J., Bai, X., Rogers, B. B., Dawson, D. B., Scheuermann, R. H., Domiati-Saad, R. (2003). Development of Real-Time PCR Assays for the Quantitative Detection of Epstein-Barr Virus and Cytomegalovirus, Comparison of TaqMan Probes, and Molecular Beacons. J. Mol. Diagn. 5: 15-20 [Abstract] [Full Text]  
  • Straathof, K. C.M., Bollard, C. M., Rooney, C. M., Heslop, H. E. (2003). Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children. The Oncologist 8: 83-98 [Abstract] [Full Text]  
  • Stevens, S. J. C., Verkuijlen, S. A. W. M., Brule, A. J. C. v. d., Middeldorp, J. M. (2002). Comparison of Quantitative Competitive PCR with LightCycler-Based PCR for Measuring Epstein-Barr Virus DNA Load in Clinical Specimens. J. Clin. Microbiol. 40: 3986-3992 [Abstract] [Full Text]  
  • He, Q., Wang, J.-P., Osato, M., Lachman, L. B. (2002). Real-Time Quantitative PCR for Detection of Helicobacter pylori. J. Clin. Microbiol. 40: 3720-3728 [Abstract] [Full Text]  
  • Collot, S., Petit, B., Bordessoule, D., Alain, S., Touati, M., Denis, F., Ranger-Rogez, S. (2002). Real-Time PCR for Quantification of Human Herpesvirus 6 DNA from Lymph Nodes and Saliva. J. Clin. Microbiol. 40: 2445-2451 [Abstract] [Full Text]  
  • van Esser, J. W. J., Niesters, H. G. M., van der Holt, B., Meijer, E., Osterhaus, A. D. M. E., Gratama, J. W., Verdonck, L. F., Lowenberg, B., Cornelissen, J. J. (2002). Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99: 4364-4369 [Abstract] [Full Text]  
  • Carpenter, P. A., Appelbaum, F. R., Corey, L., Deeg, H. J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J., Slattery, J., Levitt, D., Storb, R., Woolfrey, A., Anasetti, C. (2002). A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease. Blood 99: 2712-2719 [Abstract] [Full Text]  
  • van Laar, J. A. M., Buysse, C. M. P., Vossen, A. C. T. M., Hjalmarsson, B., van den Berg, B., van Lom, K., Deinum, J. (2002). Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis. Arch Intern Med 162: 837-839 [Abstract] [Full Text]  
  • Lankester, A. C., van Tol, M. J. D., Vossen, J. M., Kroes, A. C. M., Claas, E. (2002). Epstein-Barr virus (EBV)-DNA quantification in pediatric allogeneic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. Blood 99: 2630-2631 [Full Text]  
  • Mackay, I. M., Arden, K. E., Nitsche, A. (2002). Real-time PCR in virology. Nucleic Acids Res 30: 1292-1305 [Abstract] [Full Text]  
  • Gartner, B. C., Schafer, H., Marggraff, K., Eisele, G., Schafer, M., Roemer, K., Laws, H.-J., Sester, M., Sester, U., Einsele, H., Mueller-Lantzsch, N. (2002). Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease. J. Clin. Microbiol. 40: 351-358 [Abstract] [Full Text]  
  • van Esser, J. W. J., van der Holt, B., Meijer, E., Niesters, H. G. M., Trenschel, R., Thijsen, S. F. T., van Loon, A. M., Frassoni, F., Bacigalupo, A., Schaefer, U. W., Osterhaus, A. D. M. E., Gratama, J. W., Lowenberg, B., Verdonck, L. F., Cornelissen, J. J. (2001). Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98: 972-978 [Abstract] [Full Text]  
  • van Baarle, D., Hovenkamp, E., Callan, M. F. C., Wolthers, K. C., Kostense, S., Tan, L. C., Niesters, H. G. M., Osterhaus, A. D. M. E., McMichael, A. J., van Oers, M. H. J., Miedema, F. (2001). Dysfunctional Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 98: 146-155 [Abstract] [Full Text]  
  • Stevens, S. J. C., Pronk, I., Middeldorp, J. M. (2001). Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen. J. Clin. Microbiol. 39: 1211-1216 [Abstract] [Full Text]  
  • Jabs, W. J., Hennig, H., Kittel, M., Pethig, K., Smets, F., Bucsky, P., Kirchner, H., Wagner, H. J. (2001). Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders. J. Clin. Microbiol. 39: 564-569 [Abstract] [Full Text]  
  • Gulley, M. L. (2001). Molecular Diagnosis of Epstein-Barr Virus-Related Diseases. J. Mol. Diagn. 3: 1-10 [Abstract] [Full Text]  
  • Bai, X., Rogers, B. B., Harkins, P. C., Sommerauer, J., Squires, R., Rotondo, K., Quan, A., Dawson, D. B., Scheuermann, R. H. (2000). Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients. J. Mol. Diagn. 2: 191-201 [Abstract] [Full Text]  
  • Pas, S. D., Fries, E., De Man, R. A., Osterhaus, A. D. M. E., Niesters, H. G. M. (2000). Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays. J. Clin. Microbiol. 38: 2897-2901 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»